German Social Democrats boost support for biotechnology
This article was originally published in Clinica
Developments in biomedical research are improving our understanding of human diseases and providing new opportunities in diagnosis and therapy, says the German Social Democratic Party (SPD). Delegates at the SPD annual congress in Nuremberg last week announced that the party would intensify its support for companies that developed innovative medical products and procedures in the biomedical sector. "We should not close any doors," said research minister Edelgard Buhlmann.